Fasting Hyperglycemia and Long-term Outcome in Patients with Acute Ischemic Stroke Treated with Mechanical Thrombectomy

      Abstract

      Background

      Little is known about the prognostic role of fasting glucose after mechanical thrombectomy (MT).

      Aims

      We investigated whether fasting glucose on the next day after MT was associated with long-term outcome in acute ischemic stroke patients according to diabetes.

      Methods

      We retrospectively analyzed 181 consecutive patients with acute anterior circulation ischemic stroke who underwent MT in 2 comprehensive stroke centers in Poland. Glucose levels were evaluated on admission and on the next day after MT. Fasting hyperglycemia (FHG) was defined as the glucose level above 5.5 mmol/L. Unfavorable outcome was defined as modified Rankin scale (mRS) of 3-6 at day 90 from stroke onset.

      Results

      Patients with FHG had higher mRS at 3-month follow-up compared with those without FHG (3.71 ± 2.56 versus 1.87 ± 2.22, P < .001). In the subgroup analyses, FHG was associated with poor neurological outcome in the group without diabetes (3.74 ± 2.52 versus 1.81 ± 3.74, P < .001) but not with diabetes (3.64 ± 2.67 versus 2.30 ± 3.74, P= .11). Patients without diabetes who had FHG were older, had higher glucose on admission, higher prevalence of atrial fibrillation, cardioembolic stroke etiology and bleeding brain complications compared with the group with normal fasting glucose. After adjustment for potential confounders, fasting glucose (odds ratio [OR] 1.46; 95% CI 1.19-1.79, P < .001), age (OR 1.06; 95% CI 1.02-1.10, P = .001), successful reperfusion (OR 0.09; 95% CI 0.04-0.22, P < .001) and baseline NIHSS score (OR 1.18; 95% CI 1.08-1.29, P < .001) were predictors of mRS 3-6 at 3-month follow-up in the whole group. In the subgroup without diabetes, fasting glucose (OR 1.57; 95% CI 1.17-2.11, P = .002), age (OR 1.05; 95% CI 1.01-1.08, P = .008), successful reperfusion (OR 0.11; 95% CI 0.04-0.30, P < .001) and baseline NIHSS score (OR 1.14; 95% CI 1.04-1.26, P = .011) were independent predictors of unfavorable 3-month outcome.

      Conclusions

      Fasting glucose on the next day after MT in patients with acute ischemic stroke is an independent risk factor for worse 3-month outcome.

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Saqqur M.
        • Shuaib A.
        • Alexandrov A.V.
        • et al.
        The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
        Int J Stroke. 2015; 10: 1087-1092
        • Cao W.
        • Ling Y.
        • Wu F.
        • et al.
        Higher fasting glucose next day after intravenous thrombolysis is independently associated with poor outcome in acute ischemic stroke.
        J Stroke Cerebrovasc Dis. 2015; 24: 100-103
        • Lu G.D.
        • Ren Z.Q.
        • Zhang J.X.
        • et al.
        Effects of diabetes mellitus and admission glucose in patients receiving mechanical thrombectomy: a systematic review and meta-analysis.
        Neurocrit Care. 2018; 29: 426-434
        • Osei E.
        • den Hertog H.M.
        • Berkhemer O.A.
        • et al.
        Increased admission and fasting glucose are associated with unfavorable short-term outcome after intra-arterial treatment of ischemic stroke in the MR CLEAN pretrial cohort.
        J Neurol Sci. 2016; 371: 1-5
        • Chen X.
        • Liu Z.
        • Miao J.
        • et al.
        High stress hyperglycemia ratio predicts poor outcome after mechanical thrombectomy for ischemic stroke.
        J Stroke Cerebrovasc Dis. 2019; 28: 1668-1673
        • Johnston K.C.
        • Bruno A.
        • Pauls Q.
        • et al.
        Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial.
        JAMA. 2019; 322: 326-335
        • Zinman B.
        • Wanner C.
        • Lachin J.M.
        • et al.
        Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
        N Engl J Med. 2015; 373: 2117-2128
        • Słowik A.
        • Wnuk M.
        • et al.
        • Polish Thrombectomy Initiative
        Mechanical thrombectomy in acute stroke - five years of experience in Poland.
        Neurol Neurochir Pol. 2017; 51: 339-346
        • American Diabetes Association
        Standards of medical care in diabetes 2014.
        Diabetes Care. 2014; 37: S81-S90
        • Baker L.
        • Juneja R.
        • Bruno A.
        Management of hyperglycemia in acute ischemic stroke.
        Curr Treat Options Neurol. 2011; 13: 616-628
        • Trouillas P.
        • von Kummer R.
        Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke.
        Stroke. 2006; 37: 556-561
        • Gordon W.R.
        • Salamo R.M.
        • Behera A.
        • et al.
        Association of blood glucose and clinical outcome after mechanical thrombectomy for acute ischemic stroke.
        Interv Neurol. 2018; 7: 182-188
        • Rabinstein A.A.
        • Albers G.W.
        • Brinjikji W.
        • et al.
        Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy.
        Int J Stroke. 2019; 14: 23-31
        • Szczudlik A.
        • Slowik A.
        • Turaj W.
        • et al.
        Transient hyperglycemia in ischemic stroke patients.
        J Neurol Sci. 2001; 189: 105-111
        • Dziedzic T.
        • Pera J.
        • Trabka-Janik E.
        • et al.
        The impact of postadmission glycemia on stroke outcome: glucose normalization is associated with better survival.
        Atherosclerosis. 2010; 211: 584-588
        • Osei E.
        • den Hertog H.M.
        • Berkhemer O.A.
        • et al.
        Admission glucose and effect of intra-arterial treatment in patients with acute ischemic stroke.
        Stroke. 2017; 48: 1299-1305
        • Kaesmacher J.
        • Kaesmacher M.
        • Maegerlein C.
        • et al.
        Hemorrhagic Transformations after Thrombectomy: risk Factors and Clinical Relevance.
        Cerebrovasc Dis. 2017; 43: 294-304
        • Liang J.
        • Liu W.
        • Sun J.
        • et al.
        Analysis of the risk factors for the short-term prognosis of acute ischemic stroke.
        Int J Clin Exp Med. 2015; 8: 21915-21924
        • Krinsley J.S.
        • Meyfroidt G.
        • van den Berghe G.
        • et al.
        The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients.
        Curr Opin Clin Nutr Metab Care. 2012; 15: 151-160
        • Drabik L.
        • Wolkow P.
        • Undas A.
        Fibrin clot permeability as a predictor of stroke and bleeding in anticoagulated patients with atrial fibrillation.
        Stroke. 2017; 48: 2716-2722
        • Dungan K.M.
        • Braithwaite S.S.
        • Preiser J.C.
        Stress hyperglycaemia.
        Lancet. 2009; 373: 1798-1807
        • Luitse M.J.
        • Biessels G.J.
        • Rutten G.E.
        • et al.
        Diabetes, hyperglycaemia, and ischaemic stroke.
        Lancet Neurol. 2012; 11: 261-271
        • Kim J.T.
        • Liebeskind D.S.
        • Jahan R.
        • Menon B.K.
        • Goyal M.
        • Nogueira R.G.
        • et al.
        Impact of hyperglycemia according to the collateral status on outcomes in mechanical thrombectomy.
        Stroke. 2018; 49: 2706-2714